skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration


For the enterprise that encourages use of health-related apps as part of a wellness program or other company-sanctioned initiative, due diligence is required to ensure that the apps meet baseline enterprise standards for consent, privacy, and information governance practices.


  • Independent testing of health apps has found that many lack proper privacy policies, consent procedures, disclosure of third-party data sharing, and other fundamental information governance policies.
  • While the enterprise may not be directly liable for the governance or security flaws of any particular app available to consumers, the unique position of recommending or sanctioning certain health apps for employee use (such as for a wellness program) raises enterprise risk.
  • As health apps more commonly become involved in workplace programs and are downloaded on work devices, the enterprise needs to take a firmer policy stance on their evaluation, selection, and governance.

Features and Benefits

  • Evaluates several of the governance and security flaws that can exist with common health-related apps on the market.
  • Assesses the unique risk that health app data poses in the presence of weak information governance policy.
  • Identifies key questions to ask as part of a screening process in evaluating a potential health-related app for enterprise use.
  • Assesses the benefit of building preemptive policies for health apps and grey data before regulatory bodies catch up with their own rules.

Key questions answered

  • What is the current data management status of the health-related app market?
  • What common enterprise information governance policies or practices do many health apps fail to meet?
  • In what situations might the enterprise formally recommend, sanction, or encourage the use of health apps on work-related devices?
  • What questions need to be asked when evaluating health-related apps for possible inclusion in an enterprise-sanctioned program?
  • How can the enterprise maintain best practices for health app data, even if it does not have direct ownership of the data on the apps?

Table of contents

Ovum view

  • Summary
  • Health app data is highly sensitive, but difficult to control
  • Build health app policies today, before regulators step in
  • Evaluating health apps: advice for the enterprise


  • Further reading
  • Author

Recommended Articles

  • Service Provider Markets, Consumer & Entertainment Services,...

    MWC 2018 Highlights

    By Ronan De Renesse 27 Feb 2018

    Over 20 of our senior Ovum analysts and consultants attended this year’s Mobile World Congress in Barcelona at the end of February. In between meetings, briefings and presentations, our analyst team were blogging and tweeting about key developments, trends and rumors. Have a look through our daily MWC 2018 Highlights to find out what happened.

    Topics 5G AI IoT Cloud Payments SDN/NFV Smart home

  • Internet of Things

    IoT Viewpoints 2018

    IoT Viewpoints explore the IoT opportunity in 2018 and beyond. Download our latest e-book to get our newest collection of thought leadership articles on the emerging IoT trends, technologies and opportunities.

    Topics IoT

  • Consumer & Entertainment Services

    US pay TV: Is it facing an existential threat?

    By Adam Thomas 28 Mar 2018

    With US pay TV having endured the worst year in its history, thoughts have inevitably turned to the future. The likelihood remains that the immediate future will remain highly uncomfortable for everyone except the scaled multinational digital platforms.


Have any questions? Speak to a Specialist

Europe, Middle East & Africa team - +44 (0) 207 017 7700

Asia-Pacific team - +61 (0)3 960 16700

US team - +1 646 957 8878

Email us at

You can also contact your named/allocated Client Services Executive using their direct dial.
PR enquiries - Call us at +44 788 597 5160 or email us at

Contact marketing -

Already an Ovum client? Login to the Knowledge Center now